Name: Evidence on the role of Dexmedetomidine for hyperactive delirium at the end of life
Start: 2025-08-25T06:30:00+05:30
End: 2025-08-25T07:30:00+05:30

June 2025

June 9 @ 6:30 am - 7:30 am UTC+5.5

Evidence-based management of myiasis

June 16 @ 6:30 am - 7:30 am UTC+5.5

Current recommendations and evidence for discontinuing LVADs in a palliative care setting

June 23 @ 6:30 am - 7:30 am UTC+5.5

Current evidence and recommendations for using mirtazapine in a palliative care setting

June 30 @ 6:30 am - 7:30 am UTC+5.5

Evidence, current recommendations, and management strategies for opioid-induced hyperalgesia

July 2025

July 7 @ 6:30 am - 7:30 am UTC+5.5

Evidence-based management of diarrhoea in a palliative care setting

July 14 @ 6:30 am - 7:30 am UTC+5.5

Evidence for Methylphenidate and Modafinil in a palliative care setting

July 21 @ 6:30 am - 7:30 am UTC+5.5

Evidence and recommendations for using novel adjuvants used in the management of bone pain

July 28 @ 6:30 am - 7:30 am UTC+5.5

Evidence-based consensus on the stepwise management of this patient’s neuropathic pain

August 2025

August 4 @ 6:30 am - 7:30 am UTC+5.5

Evidence on the role of Point of Care Ultrasound (POCUS) in a palliative care setting

August 11 @ 6:30 am - 7:30 am UTC+5.5

Evidence on the concept of Time Toxicity during management of patients needing palliative care

August 18 @ 6:30 am - 7:30 am UTC+5.5

Evidence on the role of Ketamine in management of depression in a palliative care setting

August 25 @ 6:30 am - 7:30 am UTC+5.5

June 2025

July 2025

August 2025

Hello!